I don't think anyone is interested in buying them. They are losing a significant amount of market share, especially in the hepatitis/HIV ab testing area. I think Abbott is making big strides in gaining market share from OCD on that end.
The 5,1's are being replaced with Olympus in the Kaiser system and the 5600's are performing poorly. Integrating an IA system into their chemistry analyzer was a bad idea especially since their IA system was prone to jams with stuck RV's if it was pushed too hard. Once you have to open up the incubator, all of those tests will have to be repeated at your cost.
Unfortunately, what are the options? Crappy Vista's or old Synchron's?
I would think Danaher would buy part of the company only to round out their IA menu with Hepatitis/HIV ab testing.
↧